
Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients
Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients
The solution is a combination of cold chain logistics, serialization compliance and distribution
With the deal, the China-based CDMO grows its US presence
Quris’s system can help predict clinical safety, AI firm notes
Software firm merges with PharmaLex Group
Collaboration, the companies note, is expected to further engage patients
USP study reveals urgency to make changes, with additional concerns coming to light amid times of crisis
Logistics provider’s investment will develop distribution area by an additional 27%
Acquisition expands Medable’s global engineering talent and gives company a third location in Europe
Branded as the Ember Cube, the container features reusability, real-time tracking and self-contained recharging of refrigerant
CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant
Acquires Medaxis, a patient engagement company
The latest people news happenings over the past month
Following a November FDA public meeting, HDA reiterates the objections it had to guidance FDA issued in mid-2021 under the Drug Supply Chain Security Act (DSCSA)
Merger with Phlexglobal expands provider’s technological capabilities
Rebrand reflects company’s plans to access to the US and Chinese markets
Expansion of the collaboration features a reduction in carbon dioxide emissions
Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers
Anticipated yearly production is 2 million units
In a civil action, Gilead alleges an extensive, transnational counterfeiting ring of HIV and other drugs
Partnership looks to ensure that chargebacks for suppliers are as accurate as possible
CellShip offers an alternative to cryopreservation, the parties note
Companies to focus on market access strategies
Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices
CDMO's new South Korean facility to offer a range of production services
The restructural changes at the pharma pubs are effective immediately
Acquisition of 86,000 square-foot plant has capability of manufacturing 1.8 billion capsules annually
Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces
Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C> sectors